Becky Opper, PA
Physician Assistant · Richland, WANPI 1811263015
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,198 of the $8,957 with a category attached, or 69.2%. It is spread thinly across 37 manufacturers, the largest accounting for just 16.7%. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 266 payments — averaging $33.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Axonics, Inc.$1K
- Astellas Pharma US Inc$1K
- Coloplast$712
- AbbVie$440
- Sumitomo Pharma America, Inc.$352
- plus $3K from 31 others
What the payments were for
- Travel & lodging$2,11624%
- Food & beverage$6,19869%
- Education$6437%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $1,499 |
| Axonics, Inc. | 10 | $1,438 |
| Astellas Pharma US Inc | 31 | $1,098 |
| Coloplast | 41 | $712 |
| AbbVie(2 entities) | 36 | $440 |
| Sumitomo Pharma America, Inc. | 19 | $352 |
| Myovant Sciences Inc. | 18 | $335 |
| Johnson & Johnson | 12 | $292 |
| Amgen | 2 | $255 |
| Medtronic | 6 | $207 |
| Pfizer | 10 | $187 |
| Urovant Sciences Inc | 12 | $185 |
| 180 Medical, Inc. | 7 | $178 |
| Endo Pharmaceuticals Inc. | 8 | $161 |
| Progenics Pharmaceuticals, Inc. | 3 | $155 |
| Alnylam Pharmaceuticals Inc. | 4 | $129 |
| Procept Biorobotics Corporation | 1 | $125 |
| Urogen Pharma, Inc. | 6 | $123 |
| Edwards Lifesciences | 1 | $123 |
| Sanofi | 1 | $118 |
| Insulet Corporation | 1 | $114 |
| Rochester Medical Corporation | 3 | $113 |
| Esperion Therapeutics, Inc. | 1 | $100 |
| Teleflex LLC | 1 | $86 |
| Genentech USA, Inc. | 1 | $68 |
| Blue Earth Diagnostics | 3 | $58 |
| Verity Pharmaceuticals Inc. | 3 | $43 |
| Merck | 2 | $43 |
| Hollister Incorporated | 2 | $35 |
| Ferring Pharmaceuticals Inc. | 1 | $34 |
| Myriad Genetic Laboratories, Inc. | 2 | $32 |
| Mission Pharmacal Company | 2 | $29 |
| Travere Therapeutics, Inc. | 1 | $25 |
| Tolmar, Inc. | 1 | $21 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Laborie Medical Technologies Corp. | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- rezum Generator$1,312
- Axonics$1,168
- KRYSTEXXA$130
- SPEEDICATH$125
- AquaBeam Robotic System$125
- Repatha$125
- DUPIXENT$118
- ORGOVYX$118
- PYLARIFY$115
- Omnipod$114
- NEXLIZET$100
- NEXLETOL$100
How this compares
$8,957 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 131 | $142,135 |
| GemtesaVibegron | 52 | $55,614 |
| Tamsulosin Hcl | 496 | $9,096 |
| PremarinEstrogens, Conjugated | 12 | $5,404 |
| Estradiol | 54 | $4,436 |
| Testosterone | 22 | $4,296 |
| Finasteride | 244 | $3,991 |
| Oxybutynin Chloride ErOxybutynin Chloride | 144 | $3,822 |
| Doxazosin Mesylate | 147 | $2,753 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 24 | $2,515 |
| Trospium Chloride | 41 | $2,376 |
| Tolterodine Tartrate ErTolterodine Tartrate | 28 | $1,995 |
| Solifenacin Succinate | 50 | $1,955 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 50 | $1,085 |
| Testosterone Cypionate | 18 | $921 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $1,098 | $142,135131 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $352 | $55,61452 claims |
| PfizerPremarin | $187 | $5,40412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.
Other physician assistant in Richland
- Jeannette HartRichland$263K
- Jill KandoraShoreline$437K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
- Regan BrownSpokane$56K
- Justin ChapinSeattle$40K
- Susan DuffyBellevue$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.